[{"path":"/safety/recalls-market-withdrawals-safety-alerts/jubilant-cadista-pharmaceuticals-inc-issues-voluntary-nationwide-recall-drospirenone-and-ethinyl","field_change_date_2":"07/23/2019","field_brand_name":"<a href=\"/safety/recalls-market-withdrawals-safety-alerts/jubilant-cadista-pharmaceuticals-inc-issues-voluntary-nationwide-recall-drospirenone-and-ethinyl\">Cadista</a>","field_product_description":"Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg","field_recall_reason_description":"Due to out of specification (OOS) dissolution results at the 3-month stability time point ","field_recall_reason":"Defect","field_company_name":"Jubilant Cadista Pharmaceuticals Inc.","field_product_type":"","term_node_tid":"","field_regulated_product_field":"","all-terms-rewrite":"","publicationDate":"2019-07-23T04:00:00.000Z","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jubilant-cadista-pharmaceuticals-inc-issues-voluntary-nationwide-recall-drospirenone-and-ethinyl","canonicalId":"c5a37165b95167f8d0cb3b59bbb190e08474964492912d6f4c12f21c9adf81ab","title":"Jubilant Cadista Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, Due to Out-of-Specification Dissolution Test Results","description":"Jubilant Cadista Pharmaceuticals Inc. is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level. The affected product is being recalled due to out-of-specification (OOS) dissolution results at the 3-month stabili","feedName":"fda","feedSource":"fda","categories":[]}]